MedPath

Cetirizine Hydrochloride

Cetirizine Hydrochloride Tablets USP 5 mg, Allergy

Approved
Approval ID

ddec7d64-ab3d-4ddd-9bcd-b7f4d2b46be7

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 21, 2022

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cetirizine Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63629-4914
Application NumberANDA077829
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cetirizine Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateDecember 12, 2017
FDA Product Classification

INGREDIENTS (8)

HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
CETIRIZINE HYDROCHLORIDEActive
Quantity: 5 mg in 1 1
Code: 64O047KTOA
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
LACTOSE, UNSPECIFIED FORMInactive
Code: J2B2A4N98G
Classification: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 12/30/2011

Cetirizine HCL 5mg Tablet

Label

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 8/16/2018

USES

Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

  • runny nose
  • sneezing
  • itchy, watery eyes
  • itching of the nose or throat

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 8/16/2018

INACTIVE INGREDIENTS

hypromellose, lactose, magnesium stearate, maize starch, polyethylene glycol, povidone, titanium dioxide.

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 8/16/2018

ACTIVE INGREDIENTS (IN EACH TABLET)

Cetirizine HCl USP 5 mg

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 8/16/2018

PURPOSE

Antihistimine

WARNINGS SECTION

LOINC: 34071-1Updated: 8/16/2018

WARNINGS:

DO NOT USE

Do Not Use if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine.

ASK DOCTOR

Ask a doctor before use if you haveliver or kidney disease. Your doctor should determine if you need a different dose.

ASK DOCTOR/PHARMACIST

Ask a doctor or pharmacist before use if you are taking tranquilizers or sedatives.

WHEN USING THIS PRODUCT

  • drowsines may occur
  • avoid alcoholic drinks
  • alcohol, sedatives, and tranquilizers may increase drowsiness
  • be careful when driving a motor vehicle or operating machinary.

STOP USE

Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.

IF PREGNANT OR BREAST-FEEDING

  • if breast-feeding: not recommended
  • if pregnant: ask a health professional before use.

KEEP OUT OF REACH OF CHILDREN

In case of overdose, get medical help or contact Poison Control Center right away. (1-800-222-1222)

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 8/16/2018

DIRECTIONS

Adults and children 6years and over

1 to 2 tablets once daily depending upon severity of symptoms; do not take more than 2 tablets in 24 hours

Adults 65 years and over

1 tablet once a day; do not take more than 1 tablet in 24 hours

Children under 6 years of age

Ask a doctor

Consumers with liver or kidney disease

Ask a doctor

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 11/2/2021

Manufactured by:

Unique Pharmaceutical Labs,

(A Div. of J. B. Chemicals & Pharmaceuticals Ltd.),

Mumbai 400 030, India.

Distributed by:

Rising Pharma Holdings, Inc.
East Brunswick, NJ 08816

M.L. G/1430 July 2020


129575

OTC - QUESTIONS SECTION

LOINC: 53413-1Updated: 7/31/2020

QUESTIONS

Call 1-844-874-7464

How Supplied Section

LOINC: 34069-5Updated: 2/21/2022

HOW SUPPLIED

NDC: 63629-4914-1: 30 Tablets in a BOTTLE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cetirizine Hydrochloride - FDA Drug Approval Details